By Jim Stallard, MA, Writer/Editor | Tuesday, February 5, 2013
In a recent discussion as part of Memorial Sloan-Kettering’s CancerSmart lecture series, bladder cancer experts spoke about symptoms, risk factors, and the latest treatment options available.
In the Lab
By Jim Stallard, MA, Writer/Editor | Friday, February 1, 2013
Researchers have shed light on how an important treatment for early-stage bladder cancer enters cancer cells to eradicate them.
By Media Staff | Wednesday, January 30, 2013
A New York State law that went into effect this month requires radiologists to inform women if they have dense breasts. Dr. Lee answers questions about the concept of breast density and what women should know.
In the Clinic
By Media Staff | Tuesday, January 29, 2013
New research suggests that analyzing genetic changes found in the bloodstream may help doctors predict which chemotherapy regimens will work for some patients.
In the O.R.
By Jim Stallard, MA, Writer/Editor | Friday, January 25, 2013
Our doctors have shown that tumors compressing the spinal cord can be controlled using less-invasive surgery combined with a precise, intense form of radiation therapy.
By Memorial Sloan-Kettering | Wednesday, January 23, 2013
When Dr. Patel meets with patients and their families, he walks them step-by-step through the treatment plan and ensures that they receive the most-effective surgery, when that is the best approach for the patient.
By Memorial Sloan-Kettering | Friday, January 18, 2013
Memorial Sloan-Kettering experts offer strategies for dealing with concerns about cancer treatments, procedures, and scans.
By Memorial Sloan-Kettering | Wednesday, January 16, 2013
Dr. Sclafani, who practices at Memorial Sloan-Kettering Commack, wants newly diagnosed patients to leave her office with hope and with a plan of action for treating the cancer.
By Memorial Sloan-Kettering | Friday, January 11, 2013
Dr. Bochner – who specializes in treating people with prostate, bladder, and kidney cancers – discusses the importance of a multidisciplinary team approach to delivering high-quality care.
In the Clinic
By Media Staff | Monday, January 7, 2013
The American Society of Clinical Oncology’s notable research advances include the approval of a new drug for men with advanced prostate cancer that was developed and studied by Memorial Sloan-Kettering researchers.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Thursday, January 3, 2013
A team from Memorial Sloan-Kettering has found that the makeup of immune cells in a lung tumor and in tissue surrounding a tumor can predict whether the cancer will recur after surgery.
On Our Website
By Memorial Sloan-Kettering | Monday, December 31, 2012
Our Office of Diversity Programs offers information and resources about clinical care, research, and training focused on reducing cancer health disparities in medically underserved populations.
By Memorial Sloan-Kettering | Friday, December 28, 2012
Dr. Barakat explains the latest surgical techniques for improving outcomes and quality of life in women with cervical, ovarian, and other gynecologic cancers.
By Julie Grisham, MS, Science Writer/Editor | Thursday, December 27, 2012
Problems with cognitive function can significantly impact a person’s quality of life after cancer treatment. New research is focused on the link between cancer treatment and cognitive changes.
In the Clinic
By Jim Stallard, MA, Writer/Editor | Friday, December 21, 2012
Memorial Sloan-Kettering researchers have shown for the first time that administering a growth factor called interleukin-7 can help patients regenerate T cells more quickly after stem cell transplantation.